Judge rejects Mylan lawsuit against FDA over generic of Diovan

12/28/2012 | Bloomberg

U.S. District Court Judge John D. Bates dismissed Mylan's lawsuit against the FDA over the rejection of a generic form of Novartis AG's heart drug Diovan. Bates said the FDA didn't act in a capricious manner and "[g]iven Mylan's status as a leading generic manufacturer and its already-large market presence, the potential financial impact on Mylan's business is too small to support a finding of irreparable harm."

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY